Sign In
Buy DXR
$10.50
-0.345 (-3.18%)
At Close: Jul 31, 2026
Contrasting Daxor (NASDAQ:DXR) and Quest Diagnostics (NYSE:DGX)
02:38am, Thursday, 05'th Feb 2026
Daxor (NASDAQ: DXR - Get Free Report) and Quest Diagnostics (NYSE: DGX - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on th
Daxor Corporation Announces $9 Million Registered Direct Offering
08:00am, Friday, 23'rd Jan 2026
OAK RIDGE, TN, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NasdaqCM: DXR) (“Daxor” or the “Company”) announced today that it has entered into a definitive agreement with fundamental i
Quest Diagnostics (NYSE:DGX) & Daxor (NASDAQ:DXR) Head-To-Head Review
01:29am, Wednesday, 07'th Jan 2026
Quest Diagnostics (NYSE: DGX - Get Free Report) and Daxor (NASDAQ: DXR - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the
Analyzing Daxor (NASDAQ:DXR) and Elanco Animal Health (NYSE:ELAN)
02:08am, Tuesday, 30'th Dec 2025
Elanco Animal Health (NYSE: ELAN - Get Free Report) and Daxor (NASDAQ: DXR - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the
Daxor (NASDAQ:DXR) Trading Down 1.4% – Here’s Why
02:40am, Friday, 12'th Dec 2025
Daxor Corporation (NASDAQ: DXR - Get Free Report)'s stock price fell 1.4% on Thursday. The stock traded as low as $12.26 and last traded at $12.33. 1,304 shares traded hands during mid-day trading, a
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
08:00am, Tuesday, 25'th Nov 2025
Continued Integration of ezBVA Lab Service and On-Site Analyzer Deployment Signals Accelerating Market Traction Oak Ridge, TN, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the gl
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
08:00am, Tuesday, 21'st Oct 2025
Summit Features a Select Group of 40 Promising Healthcare Companies at Premier Small-Cap Investor Event OAK RIDGE, TN, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global lea
Daxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSA
08:00am, Tuesday, 30'th Sep 2025
Three Studies Validate BVA-Guided Care Significantly Cuts Hospital Readmissions and Boosts Survival in High-Cost Heart Failure Segments OAK RIDGE, TN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Daxor Corporat
Daxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific Meeting
08:00am, Tuesday, 23'rd Sep 2025
Additional New Clinical Data To Be Presented Driving a New Standard of Care in Volume Measurement OAK RIDGE, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global lead
Study Demonstrates That Clinical Assessments of Fluid Status Are Often Inaccurate, Highlighting the Urgent Need for BVA and Other More Reliable Tools in Landmark Pilot Study Oak Ridge, TN, Sept. 04, 2
Daxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference
08:00am, Wednesday, 03'rd Sep 2025
Oak Ridge, TN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh wi
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
08:00am, Tuesday, 02'nd Sep 2025
Oak Ridge, TN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in
Daxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis System
07:55am, Thursday, 07'th Aug 2025
Management Expects High Demand Driven by Speed, Simplicity, and Clinical Precision Oak Ridge, TN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume m
Daxor's Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions
08:00am, Tuesday, 22'nd Jul 2025
Continued Integration of Daxor's ezBVA Lab Service and On-Site Analyzers Fuels Positive Outlook Oak Ridge, TN, July 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in b
Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
08:00am, Wednesday, 14'th May 2025
Published Research Demonstrates the Value of BVA in Meeting Key Goal of Identifying Anemia in Heart Failure Patients Oak Ridge, TN, May 14, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), Da
